Sobia Amjad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sobia Amjad has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ary Serpa Neto
Department of Intensive Care, Austin Hospital, Heidelberg, Australia
1 shared publication - Fiona McCormack
GP Liaison, Community Partnerships Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia
1 shared publication James Bailey
1 shared publication- Karin Verspoor
School of Computing and Information Systems, The University of Melbourne, Melbourne, Australia
1 shared publication Kartik Kishore
1 shared publication- Kartik Kishore
Department of Medicine Austin Health, Melbourne Medical School, The University of Melbourne, Australia; Australian Centre for Accelerating Diabetes Innovations, The University of Melbourne, Melbourne, Australia
1 shared publication
Latest Publications
- Open Access
- 18 May 2026
- Published by Elsevier in Australian Critical Care
- Vol. 39 (3) , 101603
Communication between intensive care unit doctors and general practitioners: A sequential multiphase project to increase prevalence of communication
- 18 May 2026
- Published by Elsevier in Australian Critical Care
- Vol. 39 (3) , 101603
Open AccessCommunication between intensive care unit doctors and general practitioners: A sequential multiphase project to increase prevalence of communication
- Open Access
- 17 May 2024
- Published by Elsevier in Intelligence-Based Medicine
- Vol. 9
Advancing delirium classification: A clinical notes-based natural language processing-supported machine learning model
- 17 May 2024
- Published by Elsevier in Intelligence-Based Medicine
- Vol. 9
Open AccessAdvancing delirium classification: A clinical notes-based natural language processing-supported machine learning model
- Open Access
- 4 November 2023
- Published by Springer Nature in Critical Care
- Vol. 27 (1) , 1-11
Natural language processing diagnosed behavioural disturbance phenotypes in the intensive care unit: characteristics, prevalence, trajectory, treatment, and outcomes
Background: Natural language processing (NLP) may help evaluate the characteristics, prevalence, trajectory, treatment, and outcomes of behavioural disturbance phenotypes in critically ill patients. Methods: We obtained electronic clinical notes, demographic information, outcomes, and treatment data from three medical-surgical ICUs. Using NLP, we screened for behavioural disturbance phenotypes based on words suggestive of an agitated state, a non-agitated state, or a combination of both. Results: We studied 2931 patients. Of these, 225 (7.7%) were NLP-Dx-BD positive for the agitated phenotype, 544 (18.6%) for the non-agitated phenotype and 667 (22.7%) for the combined phenotype. Patients with these phenotypes carried multiple clinical baseline differences. On time-dependent multivariable analysis to compensate for immortal time bias and after adjustment for key outcome predictors, agitated phenotype patients were more likely to receive antipsychotic medications (odds ratio [OR] 1.84, 1.35–2.51, p < 0.001) compared to non-agitated phenotype patients but not compared to combined phenotype patients (OR 1.27, 0.86–1.89, p = 0.229). Moreover, agitated phenotype patients were more likely to die than other phenotypes patients (OR 1.57, 1.10–2.25, p = 0.012 vs non-agitated phenotype; OR 4.61, 2.14–9.90, p < 0.001 vs. combined phenotype). This association was strongest in patients receiving mechanical ventilation when compared with the combined phenotype (OR 7.03, 2.07–23.79, p = 0.002). A similar increased risk was also seen for patients with the non-agitated phenotype compared with the combined phenotype (OR 6.10, 1.80–20.64, p = 0.004). Conclusions: NLP-Dx-BD screening enabled identification of three behavioural disturbance phenotypes with different characteristics, prevalence, trajectory, treatment, and outcome. Such phenotype identification appears relevant to prognostication and trial design. Graphical
- 4 November 2023
- Published by Springer Nature in Critical Care
- Vol. 27 (1) , 1-11
Open AccessNatural language processing diagnosed behavioural disturbance phenotypes in the intensive care unit: characteristics, prevalence, trajectory, treatment, and outcomes
Background: Natural language processing (NLP) may help evaluate the characteristics, prevalence, trajectory, treatment, and outcomes of behavioural disturbance phenotypes in critically ill patients. Methods: We obtained electronic clinical notes, demographic information, outcomes, and treatment data from three medical-surgical ICUs. Using NLP, we screened for behavioural disturbance phenotypes based on words suggestive of an agitated state, a non-agitated state, or a combination of both. Results: We studied 2931 patients. Of these, 225 (7.7%) were NLP-Dx-BD positive for the agitated phenotype, 544 (18.6%) for the non-agitated phenotype and 667 (22.7%) for the combined phenotype. Patients with these phenotypes carried multiple clinical baseline differences. On time-dependent multivariable analysis to compensate for immortal time bias and after adjustment for key outcome predictors, agitated phenotype patients were more likely to receive antipsychotic medications (odds ratio [OR] 1.84, 1.35–2.51, p < 0.001) compared to non-agitated phenotype patients but not compared to combined phenotype patients (OR 1.27, 0.86–1.89, p = 0.229). Moreover, agitated phenotype patients were more likely to die than other phenotypes patients (OR 1.57, 1.10–2.25, p = 0.012 vs non-agitated phenotype; OR 4.61, 2.14–9.90, p < 0.001 vs. combined phenotype). This association was strongest in patients receiving mechanical ventilation when compared with the combined phenotype (OR 7.03, 2.07–23.79, p = 0.002). A similar increased risk was also seen for patients with the non-agitated phenotype compared with the combined phenotype (OR 6.10, 1.80–20.64, p = 0.004). Conclusions: NLP-Dx-BD screening enabled identification of three behavioural disturbance phenotypes with different characteristics, prevalence, trajectory, treatment, and outcome. Such phenotype identification appears relevant to prognostication and trial design. Graphical